Laboratory studies on mecillinam: activity alone and combined with cephradine

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Gram-negative bacterial infections pose significant therapeutic challenges.
• Mecillinam (MC) is an antibiotic with a unique mechanism of action.
• Understanding MC's spectrum of activity and resistance patterns is crucial.

Purpose of the Study:

• To evaluate the inhibitory activity of Mecillinam against Gram-negative bacteria.
• To determine methods for predicting bacterial sensitivity to Mecillinam.
• To investigate the synergistic or additive effects of Mecillinam in combination with cephradine.

Main Methods:

• Disk diffusion assay using 10 microgram Mecillinam disks to assess bacterial sensitivity.
• Testing of ampicillin-resistant strains to evaluate cross-resistance.
• Combination studies with Mecillinam and cephradine against various Gram-negative species.

Main Results:

• Mecillinam demonstrated low-concentration inhibitory activity against a broad spectrum of Gram-negative bacteria.
• Sensitivity to Mecillinam was predictable using a 10 microgram disk.
• Resistance to Mecillinam was not linked to beta-lactamase activity.
• Ampicillin-resistant strains exhibited reduced sensitivity to Mecillinam.
• Synergistic effects of Mecillinam and cephradine were observed against Proteus mirabilis, Pr. vulgaris, Prov. stuartii, and Serratia marcescens.
• Additive effects were noted for Mecillinam and cephradine against Klebsiella aerogenes, Enterobacter spp., and Escherichia coli.

Conclusions:

• Mecillinam is a potent agent against Gram-negative bacteria, with predictable sensitivity.
• Beta-lactamase production does not confer resistance to Mecillinam.
• Combination therapy with Mecillinam and cephradine offers potential for enhanced treatment of specific Gram-negative infections.